— · Financial Statements

CeriBell, Inc. (CBLL) Financial Statements

$27.13 —: CBLL Market Cap $1.04B

CeriBell, Inc. most recently reported annual revenue of $89.0M, a net loss of $53.0M. Revenue grew at an average annual rate of 50.7% over the last 3 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

CeriBell, Inc.: Revenue rose from $26.0M in 2022 to $89.0M in 2025, a change of +242.3% over 3 years; net profit was positive in 0 of 4 reported years; operating margin moved from -139.0% to -65.6%, a shift of +73.4 percentage points; the most recent year shows a net loss of $53.0M.

Income Statement — 4 Years (USD millions)

Metric2022202320242025
Revenue$26.0M$45.0M$65.0M$89.0M
Operating Expenses$62.0M$75.0M$105.0M$147.0M
Operating Profit$-36.0M$-30.0M$-40.0M$-58.0M
Operating Margin-139.0%-66.4%-60.7%-65.6%
Other Income$-1.0M$1.0M$-1.0M$5.0M
Interest$2.0M$2.0M$2.0M$2.0M
Depreciation$0$1.0M$1.0M$1.0M
Profit Before Tax$-37.0M$-29.0M$-40.0M$-53.0M
Tax$-10,000$-40,000$0$0
Net Profit$-37.0M$-29.0M$-40.0M$-53.0M
EPS$-1.59$-1.26$-1.13$-1.46
Dividend Payout0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

2 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$12.0M$13.0M$15.0M$15.0M$17.0M$19.0M$20.0M$21.0M$23.0M$25.0M$26.0M$28.0M
Operating Expenses$19.0M$22.0M$23.0M$23.0M$27.0M$31.0M$35.0M$36.0M$37.0M$39.0M$47.0M$48.0M
Operating Profit$-7.0M$-8.0M$-8.0M$-8.0M$-10.0M$-13.0M$-14.0M$-15.0M$-15.0M$-15.0M$-21.0M$-20.0M
Operating Margin-61.7%-63.8%-56.8%-56.8%-57.8%-69.5%-69.3%-70.5%-64.8%-58.9%-78.3%-71.1%
Interest$1.0M$1.0M$0$0$1.0M$0$0$0$0$0$0$0
Profit Before Tax$-7.0M$-8.0M$-9.0M$-9.0M$-10.0M$-13.0M$-13.0M$-14.0M$-13.0M$-14.0M$-20.0M$-19.0M
Tax$0$0$0$0$0$0$0$0$0$0$0$0
Net Profit$-7.0M$-8.0M$-9.0M$-9.0M$-10.0M$-13.0M$-13.0M$-14.0M$-13.0M$-14.0M$-20.0M$-19.0M
EPS$-0.30$-0.35$-0.25$-0.26$-0.31$-0.40$-0.36$-0.38$-0.37$-0.36$-0.52$-0.51

Over the 4 years reported for CeriBell, Inc., borrowings increased from $18.0M in 2022 to $22.0M in 2025, cash stood at $40.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 9.84 times.

Balance Sheet — 4 Years (USD millions)

Metric2022202320242025
Total Assets$86.0M$59.0M$225.0M$196.0M
Current Assets$80.0M$52.0M$217.0M$187.0M
Cash$68.0M$34.0M$194.0M$40.0M
Inventory$4.0M$6.0M$7.0M$7.0M
Receivables$5.0M$8.0M$11.0M$15.0M
Fixed Assets$4.0M$4.0M$4.0M$4.0M
Capital Work in Progress$0$0$0$0
Investments$0$0$0$119.0M
Other Assets$0$0$0$0
Total Liabilities$173.0M$171.0M$34.0M$40.0M
Current Liabilities$10.0M$22.0M$13.0M$19.0M
Borrowings$18.0M$14.0M$22.0M$22.0M
Other Liabilities$155.0M$157.0M$12.0M$18.0M
Equity$0$0$0$0
Reserves$-86.0M$-112.0M$191.0M$155.0M

For CeriBell, Inc., operating cash flow was positive in 0 of 4 reported years; free cash flow in the latest year was negative at $42.0M; free cash flow was positive in 0 of 4 years.

Cash Flow Statement — 4 Years (USD millions)

Metric2022202320242025
Operating Cash Flow$-32.0M$-29.0M$-35.0M$-41.0M
Investing Cash Flow$-2.0M$-3.0M$-3.0M$-119.0M
Financing Cash Flow$0$1.0M$0$0
Net Cash Flow$16.0M$-34.0M$160.0M$-154.0M
Free Cash Flow$-33.0M$-30.0M$-36.0M$-42.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.70
EV / EBITDA-14.08
FCF Yield-6.27%
Quick Ratio8.79
Interest Coverage-38.57
Return 1Y3.37%
Return 3Y—
Return 5Y—

CeriBell, Inc. (CBLL) financials — frequently asked questions

What is CeriBell, Inc.'s annual revenue?

CeriBell, Inc. (CBLL) reported annual revenue of $89.0M in its most recent fiscal year.

What is CeriBell, Inc.'s net profit?

CeriBell, Inc. (CBLL) reported a net loss of $53.0M in its most recent fiscal year.

What is CBLL EV/EBITDA?

CeriBell, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -14.08. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
CBLL Overview CBLL Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.